Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil McHugh

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
Molecular Immunology|November 25, 2015
Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritisJürgen Dieker, Wolfgang Schlumberger, Neil McHugh, et al.
Rheumatology (Oxford, England)|October 29, 2014
Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literatureFrank Behrens, Juan D Cañete, Ignazio Olivieri, et al.
Rheumatology (Oxford, England)|December 28, 2018
Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritisPhilip D H Hamann, Gavin Shaddick, Kimme Hyrich, et al.
Social Science & Medicine (1982)|December 26, 2017
Are life-extending treatments for terminal illnesses a special case? Exploring choices and societal viewpointsNeil McHugh, Job van Exel, Helen Mason, et al.
Health Economics|January 20, 2018
Is "end of life" a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatmentsHelen Mason, Marissa Collins, Neil McHugh, et al.
The Journal of Rheumatology|May 3, 2014
Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associationsMartin Klein, Heřman Mann, Lenka Pleštilová, et al.
The Journal of Rheumatology|February 8, 2006
Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard"Deborah P M Symmons, Mark Lunt, Gillian Watkins, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritisWilliam Tillett, Deepak Jadon, Gavin Shaddick, et al.
BMC Rheumatology|December 9, 2020
Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational studyJesus Miguens Blanco, Federica Borghese, Neil McHugh, et al.
Rheumatology (Oxford, England)|September 12, 2018
Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort studyRachel Charlton, Amelia Green, Gavin Shaddick, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Molecular Immunology|November 25, 2015
Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritisJürgen Dieker, Wolfgang Schlumberger, Neil McHugh, et al.
Rheumatology (Oxford, England)|October 29, 2014
Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literatureFrank Behrens, Juan D Cañete, Ignazio Olivieri, et al.
Rheumatology (Oxford, England)|December 28, 2018
Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritisPhilip D H Hamann, Gavin Shaddick, Kimme Hyrich, et al.
Social Science & Medicine (1982)|December 26, 2017
Are life-extending treatments for terminal illnesses a special case? Exploring choices and societal viewpointsNeil McHugh, Job van Exel, Helen Mason, et al.
Health Economics|January 20, 2018
Is "end of life" a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatmentsHelen Mason, Marissa Collins, Neil McHugh, et al.
The Journal of Rheumatology|May 3, 2014
Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associationsMartin Klein, Heřman Mann, Lenka Pleštilová, et al.
The Journal of Rheumatology|February 8, 2006
Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard"Deborah P M Symmons, Mark Lunt, Gillian Watkins, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritisWilliam Tillett, Deepak Jadon, Gavin Shaddick, et al.
BMC Rheumatology|December 9, 2020
Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational studyJesus Miguens Blanco, Federica Borghese, Neil McHugh, et al.
Rheumatology (Oxford, England)|September 12, 2018
Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort studyRachel Charlton, Amelia Green, Gavin Shaddick, et al.
Pageof 14